MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Thor Industries stock trades near the low end of its range amid an RV industry slump, but steady dividends, institutional buying, and analyst price targets suggest upside potential ahead.
AGF Management (TSE:AGF.B) reported third-quarter 2026 adjusted diluted earnings per share of CAD 0.49, adjusted EBITDA of CAD 49 million and free cash flow of CAD 39 million, as growth in assets under management and retail sales momentum supported results.
Chief Executive Officer Judy Goldring sai
Regeneron Pharmaceuticals (NASDAQ:REGN) executives highlighted continued growth across key marketed products, a broad late-stage pipeline and an ongoing focus on science-driven business development during a discussion with Bernstein analyst Jeffrey Walch.
Chris Fenimore, Regeneron’s executive vice
Paychex (NASDAQ:PAYX) reported a solid start to fiscal 2027, posting first-quarter revenue growth of 6% and double-digit gains in operating income and earnings per share as growth in its professional employer organization, or PEO, and insurance businesses outpaced expectations.
Total first-quarter
Cintas (NASDAQ:CTAS) reported fiscal 2027 first-quarter revenue of $3.01 billion, up 10.9% from a year earlier and marking the first time the company exceeded $3 billion in quarterly revenue. Organic revenue growth, which excludes acquisitions, foreign currency movements and workday differences, was
Kratos Defense and GE Aerospace ignited their jointly developed GEK800 turbofan engine on Sept. 21, 2026, a milestone for scalable, low-cost drone and cruise missile propulsion.
Moderna (NASDAQ:MRNA) executives emphasized the company’s evolution beyond COVID-19 vaccines during a discussion with Bernstein, highlighting its mRNA platform, personalized cancer vaccine program intismeran, rare-disease pipeline and plans to expand therapeutics development.
Chief Executive Office
Sandisk joined the S&P 100 this week, but analysts say the rally stems more from strong NAND demand and record earnings than index inclusion, even as valuation suggests peak earnings cycle.
NVIDIA, Microsoft, Alphabet, and Palantir are monetizing AI through distinct moats, from hardware and cloud services to advertising and safety-focused data orchestration, driving cash flow and shareholder returns.
Worthington Enterprises (NYSE:WOR) reported a 13% increase in fiscal 2027 first-quarter sales to $344 million, supported by 7% organic growth and $19 million of revenue from recent acquisitions. Adjusted earnings per share rose to $0.82 from $0.78 a year earlier, while adjusted EBITDA increased 10%
Jim DeMare, co-president of Bank of America (NYSE:BAC), said the bank continues to see signs of resilience in the U.S. economy, while identifying relationship expansion, international operations, wealth management and technology as major growth priorities.
Speaking at a conference in London, DeMare
NB Private Equity Partners (LON:NBPE) reported a 1.9% net asset value total return in U.S. dollar terms for the first half, or 3.4% in sterling, as private investment valuation gains offset a limited number of markdowns across the portfolio.
The company also said its August monthly NAV rose 1.7%, p
Cracker Barrel Old Country Store (NASDAQ:CBRL) reported fourth-quarter fiscal 2026 revenue of $849.3 million and adjusted EBITDA of $62.1 million, as the restaurant-and-retail operator cited improving traffic trends, stronger guest metrics and continued momentum in its turnaround efforts.
Adjusted
Pasqal is partnering with USA Rare Earth and Riven Systems to apply quantum computing to rare earth separation chemistry, though Pasqal's stock remains largely untested.
Boeing won a $562 million Navy drone contract and Lockheed Martin secured over $1.3 billion in awards, yet both stocks saw little market reaction due to differing valuation concerns.
Eli Lilly leads Novo Nordisk in GLP-1 market share and analyst sentiment, while Novo pins hopes on its CagriSema catalyst and pipeline to offset patent-cliff pressure and lawsuits.
Elixirr International (LON:ELIX) reported record first-half results for 2026, with revenue rising 25% and adjusted EBITDA increasing 29%, as the consulting firm cited growing demand for artificial intelligence services, deeper client relationships and contributions from recent acquisitions.
Co-Foun
Deutsche Bank Aktiengesellschaft (NYSE:DB) CFO Raja Akram said the lender has started its 2028 strategy cycle strongly, citing a record first half, return on tangible equity close to 12%, continued asset gathering in wealth management and improved momentum in its Corporate Bank.
Akram said Germany’
Corning, Cisco Systems, and Texas Instruments are repositioning around AI infrastructure needs, showing earnings growth, steady margins, dividends, and Moderate Buy analyst ratings with notable upside targets.
Tech stocks broke out this week as the QQQ neared record highs. Microsoft, Atlassian, and Hewlett Packard Enterprise show supportive fundamentals and technical setups that could extend gains if the sector's momentum holds.
General Mills (NYSE:GIS) said its fiscal 2027 first-quarter results came in ahead of its expectations as improved retail trends and early cost-savings progress helped offset continued input-cost pressure. The company reaffirmed its full-year outlook, while emphasizing innovation, supply-chain transf
Teva Pharmaceutical Industries (NYSE:TEVA) is planning for greater financial flexibility after receiving investment-grade ratings from all three major credit rating agencies, President and CEO Richard Francis said at the BofA Global Healthcare Conference.
Francis said the company achieved the miles
SThree (LON:STEM) said its third-quarter performance improved sequentially as contract new-business activity increased, productivity rose and recovery signals broadened across more markets. The STEM-focused recruitment company raised its full-year profit-before-tax expectation to at least £12 millio
AutoZone's earnings showed sustained comps growth, margin gains, and buybacks, with analysts holding a Moderate Buy rating and price targets suggesting more than 30% upside.
Agilent Technologies (NYSE:A) executives outlined continued growth momentum, driven by improving end markets, market-share gains, instrument replacement cycles and operational changes under the company’s Ignite transformation program, during a J.P. Morgan conference discussion.
Chief Executive Offi
GSK (NYSE:GSK) Chief Financial Officer Julie Brown outlined the company’s growth strategy, launch priorities and cost-savings plans during a discussion with Bank of America analyst Sachin Jain following the company’s recent capital markets day.
Brown said GSK’s strategic portfolio review identified
Ceres Power (LON:CWR) said it remains confident of signing a new manufacturing licensee this year as it seeks to capitalize on growing demand for on-site power generation, while reporting progress toward its contracted revenue target and continued cost reductions.
Chief Executive Officer Phil Caldw
Renishaw (LON:RSW) reported higher revenue, profit and margins for fiscal 2026, supported by strong demand for position encoders used in semiconductor equipment and by growth in additive manufacturing.
Revenue rose 14% to £816 million, or 17% at constant exchange rates, while adjusted operating pro
General Motors (NYSE:GM) Chief Financial Officer Paul Jacobson said the automaker remains on track to finish 2026 near the higher end of its full-year guidance after raising its outlook twice this year, citing continued consumer resilience, disciplined inventory management and a broad vehicle portfo
ATI (NYSE:ATI) has transformed its portfolio toward aerospace and defense markets, with those end markets now representing about 70% of total revenue, President and CEO Kim Fields said during a Morgan Stanley aerospace and defense conference panel.
Fields said the company’s shift began in 2019, whe
UBS Group (NYSE:UBS) Chief Executive Officer Sergio Ermotti said proposed Swiss capital rules could impose substantial costs on the bank and create a competitive disadvantage, while also outlining continued progress on the integration of Credit Suisse and growth plans across wealth management.
Spea
UiPath (NYSE:PATH) used its investor day to outline a strategy centered on business orchestration and automation, arguing that enterprises will need governed systems to deploy artificial intelligence across complex business processes.
Founder and CEO Daniel Dines said the company has grown revenue
Barclays (NYSE:BCS) CFO Anna Cross said the bank continues to see resilient conditions among U.K. consumers and businesses, supporting loan growth across retail and corporate banking, while the company invests in technology, expands its U.S. consumer offering and works to reduce its structural cost
Neurocrine Biosciences (NASDAQ:NBIX) outlined its commercial growth priorities, pricing considerations and pipeline plans during a Morgan Stanley discussion, with CEO Kyle Gano emphasizing the company’s efforts to diversify beyond its largest product, INGREZZA.
Gano said China has become both a com
Ocular Therapeutix (NASDAQ:OCUL) said it remains on track to submit a U.S. marketing application for AXPAXLI in the fourth quarter of this year, following what Chief Executive Officer Pravin Dugel described as alignment with the Food and Drug Administration on the company’s planned submission packag
Bank Of Montreal (NYSE:BMO) Chief Financial Officer Rahul Nalgirkar said the bank is seeing stronger client activity and loan demand despite uncertainty surrounding Canada-U.S. trade negotiations, while maintaining its focus on improving returns through core operating performance.
Speaking at an in
Qualcomm (NASDAQ:QCOM) used its Snapdragon Summit 2026 keynote to outline its strategy for “agentic” artificial intelligence, positioning smartphones and other connected devices as personal AI endpoints that can understand context, coordinate tasks and act on users’ behalf.
President and CEO Cristi
Anheuser-Busch InBev SA/NV (NYSE:BUD) used its 2026 Capital Markets Day in St. Louis to outline the next phase of its 10-year strategy, emphasizing organic growth, portfolio expansion, digital platforms and increased capital-allocation flexibility.
Chief Executive Officer Michel Doukeris said the b
KB Home (NYSE:KBH) reported third-quarter fiscal 2026 results that met or exceeded its guidance despite what executives described as a more difficult housing environment marked by rising mortgage rates, affordability pressures, higher resale inventory and cautious consumers.
The homebuilder generat
Fastly (NASDAQ:FSLY) outlined a strategy centered on expanding its unified edge cloud platform, increasing multi-product adoption, broadening its geographic reach and targeting revenue of $1.1 billion to $1.3 billion by 2029 at its Investor Day.
Chief Executive Officer Kip Compton said the company
Abeona Therapeutics (NASDAQ:ABEO) highlighted the early commercial progress of ZEVASKYN, its autologous gene-modified cellular sheet therapy for recessive dystrophic epidermolysis bullosa (RDEB), during the H.C. Wainwright 28th Annual conference.
Madhav Vasanthavada, Abeona’s senior vice president
Compass Pathways (NASDAQ:CMPS) said it remains on track to complete its rolling New Drug Application submission for COMP360 in the fourth quarter of 2026, following positive Phase III studies of its synthetic psilocybin treatment in treatment-resistant depression, or TRD.
During H.C. Wainwright’s G
J.B. Hunt Transport Services (NASDAQ:JBHT) said demand for its freight services has remained strong across most business lines, while higher driver-related expenses, fuel costs and claims costs are expected to pressure third-quarter earnings relative to the second quarter.
Chief Financial Officer a
Compass Pathways (NASDAQ:CMPS) expects to complete its new drug application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, in the fourth quarter, with a potential U.S. launch in the first half of 2027, executives said at the Morgan Stanley Global
Arm Holdings shares jumped 17% on reports of a Meta custom-chip partnership and a $2 billion AI processor target, though elevated valuation multiples and foundry supply constraints temper near-term upside.
Oura's IPO targets a $12.8B-$14.1B valuation, pricing shares at $40-$44 ahead of its Nasdaq debut, backed by Eli Lilly interest and strong subscription revenue growth.
Cognex (NASDAQ:CGNX) said it has entered into a definitive agreement to acquire RealSense, a provider of depth-sensing cameras and vision technology used in robotic perception and physical AI applications.
The transaction is intended to expand Cognex’s machine-vision portfolio into 3D depth percept
Octopus Renewables Infrastructure Trust (LON:ORIT) said its first-half revenue and EBITDA exceeded budget despite a negative net asset value total return, as strong solar and offshore wind performance offset weaker onshore wind production.
Co-Fund Manager Chris Gaydon said the renewable energy inve
AMD shares topped $620 and its market cap surpassed $1 trillion, driven by major deals with OpenAI and Oracle, strong data center revenue growth, and rising pricing power.
Falling oil prices and easing inflation may set up the Fed for a larger rate cut ahead, a move that could revive the housing market and support the S&P 500's longer-term uptrend.
DraftKings (NASDAQ:DKNG) CEO and Chairman Jason Robins said the company is seeing strong early-season engagement across its core sportsbook business and its newer prediction markets offering, while maintaining its expectation of about $1 billion in adjusted EBITDA for 2026.
Speaking with Wells Farg
IonQ and partners at Oak Ridge National Laboratory and NVIDIA used generative AI to speed quantum circuit design, cutting runtime dramatically, though commercial impact remains unclear.
CEO Hock Tan defended Broadcom's $350 billion AI chip outlook amid Anthropic's calls to slow frontier AI development, citing the company's inference-focused customer relationships.
AutoZone (NYSE:AZO) reported fiscal 2026 fourth-quarter sales growth of 5.6% to $6.6 billion, while diluted earnings per share rose 15.1% to $56.05. The company said its results included a $96 million benefit from tariff refunds and a $15 million non-cash LIFO charge.
For the full fiscal year, sale
Celldex Therapeutics (NASDAQ:CLDX) reported positive top-line results from its two Phase III EMBARQ-CSU studies of barzolvolimab in adults with chronic spontaneous urticaria, or CSU, who remained symptomatic despite H1 antihistamine treatment. The company said both evaluated dose regimens met the pr
ACG Acquisition (LON:ACG) said its updated technical report for the Gediktepe mining operation in Türkiye increased the project’s estimated net present value and lifted expected copper-equivalent production over the next five years.
Artem, the company’s chair and chief executive officer, said Gedik
Microsoft raised its quarterly dividend 7.69% to 98 cents per share, marking 23 straight years of increases even as AI-related capital spending pressures free cash flow.
Analog Devices (NASDAQ:ADI) Chief Financial Officer Rich Puccio said the company expects demand strength across its portfolio to support double-digit growth into fiscal 2027, citing broad-based recovery in industrial markets alongside continued momentum in data centers, aerospace and defense, and au
A multi-state settlement cleared the main legal hurdle to Paramount Skydance's $111 billion Warner Bros. Discovery deal, requiring production and labor concessions as WBD and PSKY shares reacted sharply.
Apple's market cap has climbed to roughly $4.95 trillion on strong iPhone demand, closing in on NVIDIA's approximately $5.48 trillion, as investors watch whether Apple can overtake the AI chipmaker again.
MillerKnoll (NASDAQ:MLKN) reported first-quarter fiscal 2027 sales and orders that reflected uneven demand across its businesses, as strong International Contract and Global Retail order trends were offset by softer-than-expected North America Contract activity.
For the quarter ended Aug. 29, 2026,
Viking Therapeutics (NASDAQ:VKTX) reported top-line results from a maintenance dosing study of VK2735, its dual GLP-1/GIP receptor agonist candidate for obesity, showing that participants retained much of their initial weight loss after transitioning from weekly treatment to every-other-week or mont
Oxford Biomedica (LON:OXB) reported higher first-half revenue and improved operating EBITDA as manufacturing activity increased, while management reiterated its full-year 2026 revenue guidance and longer-term growth targets.
Revenue for the six months ended in 2026 rose 10% at constant currency to
Meta Platforms unveiled Petal, a petabit-scale subsea cable linking the U.S. and France, boosting demand for optical infrastructure suppliers like Corning amid AI-driven data center buildouts.
Goldman Sachs cut its Tesla delivery estimates for the third and fourth quarters, but shares held near recent highs as investors focus on Tesla's robotaxi and AI ambitions instead.
Encore Capital Group's stock has more than doubled as record debt collections and rising charge-offs drove Q2 earnings beats, prompting raised full-year guidance and bullish analyst ratings.
Cybin (NASDAQ:HELP), doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider resolutions related to the company’s auditor, board size, corporate name and director elections.
Eric So, the company’s co-founder and executiv
Here Group reported fourth-quarter revenue of CNY127.7 million for fiscal 2026, an increase of 94.1% from a year earlier, as sales of existing and newly launched pop-toy intellectual property products rose. Full-year revenue reached CNY596.8 million, according to Founder, Chairman and Chief Executiv
Texas Roadhouse posted record sales and revenue growth in Q2, but rising beef costs squeezed margins, sending shares down 19% despite a Moderate Buy analyst consensus.
Pfizer (NYSE:PFE) has rebuilt its commercial model around newer and acquired products while reducing exposure to its COVID-19 franchise, according to Alexandre de Germay, the company’s chief international commercial officer and executive vice president.
Speaking with Chris Schott at a company event
Nucor and Steel Dynamics shares are pulling back after Q3 guidance missed estimates, but higher steel prices, strong backlogs, and wide margins support analysts' bullish price targets.
Amazon struck a deal worth up to $8 billion with Generac for backup generators to power its AI data centers, underscoring how electricity supply has become a critical bottleneck in its AI buildout.
Sanofi (NASDAQ:SNY) is reviewing its late-stage pipeline, broadening its business-development lens and working to rebuild early research output under new leadership, Chief Scientific Officer and Global Head of Research Mike Quigley said at a Bank of America event.
Quigley said Chief Executive Offic
PureTech Health (NASDAQ:PRTC) outlined progress across its portfolio in its 2026 half-year results call, highlighting external financings for Celea Therapeutics and Seaport Therapeutics, regulatory progress at Gallop Oncology, and a strategy centered on earlier external funding for its founded entit
